Tag: biotech company
CSIRO & Padula Serums develop snakebite antivenom for man’s best friend
The CSIRO has teamed up with Padula Serums to develop effective and low cost antivenom to treat dogs for snake bites.
Australia is home to...
Melbourne start-up MecRx secures $4 million investment to accelerate anti-cancer drugs discovery
A risk-sharing agreement with CSIRO saw Melbourne start-up biotech company MecRx secure a $4 million investment from the Medical Research Commercialisation Fund (MRCF) to...
Featured Article
Navigating energy price volatility with predictive intelligence
Energy price volatility has become a structural feature of modern electricity markets rather than a temporary disruption. For energy-intensive manufacturers and large commercial operators, fluctuating wholesale prices are reshaping how energy costs are managed, making reactive approaches increasingly inadequate.
